Insulin-like growth factor 2 (IGF2) is expressed in and secreted by brain pericytes, and blocking IGF1R with the selective IGFR1 inhibitor picropodophyllin was shown to reduce BC cell proliferation and adhesion and to reduce the size of 4T1 brain metastatic lesions [138]. Here, IGF2 is linked to breast cancer.